Digestive Health Drinks & Food Market by Product Type (Drinks, Foods), Ingredient Type (Prebiotics, Probiotics, Synbiotics), Form, Age Group, Distribution Channel - Global Forecast 2025-2032
Description
The Digestive Health Drinks & Food Market was valued at USD 14.14 billion in 2024 and is projected to grow to USD 15.02 billion in 2025, with a CAGR of 6.72%, reaching USD 23.81 billion by 2032.
A modern orientation to digestive health beverages and functional foods that explains evolving consumer motivations, clinical validation trends and cross-sector innovation dynamics
The digestive health drinks and functional foods category has matured from niche wellness fare into a mainstream platform for nutrition-led consumer engagement, supported by expanding scientific evidence and diversified ingredient technology. Consumers now approach digestive wellness through multiple avenues: daily preventative routines, condition-specific management, and integrative approaches that pair nutrition with lifestyle behaviors. These drivers have informed a broader ecosystem in which product developers, ingredient suppliers, clinicians, and retailers collaborate to translate biological mechanisms into credible consumer propositions. As a result, formulations emphasize tangible physiological benefits that are communicated with greater clarity and regulatory consciousness.
At the same time, commercial actors are balancing sensory experience, convenience, and efficacy to broaden appeal beyond motivated early adopters. Packaging innovations, portion formats, and hybrid product concepts aim to lower barriers to trial while preserving functional integrity. In parallel, industry stakeholders are investing in evidence generation-ranging from in vitro assays to real-world consumer studies-to underpin claims and differentiate offerings in a crowded shelf set. These intersecting trends are reshaping how digestive health products are developed, marketed, and distributed, creating a landscape where scientific legitimacy and consumer-centric design jointly determine competitive positioning.
How ingredient science, consumer expectations, omnichannel distribution and regulatory focus are jointly reshaping product development and commercial strategies in digestive health
Several transformative shifts are reconfiguring the digestive health category, driven by advances in ingredient science, shifts in consumer behavior, and new go-to-market models. Ingredient innovation is expanding beyond traditional probiotic strains to include targeted prebiotics, synbiotic combinations, and strain-specific applications that address distinct physiological pathways. These advances are enabling more precise product positioning-whether aimed at daily microbiome maintenance, post-antibiotic recovery, or symptom-focused relief-while increasing demands for transparent sourcing and traceability.
Consumer expectations are evolving as well: convenience and multisensory pleasure now coexist with a requirement for credible health outcomes and ethical practices. Digital-native shoppers are using online resources to validate claims and compare ingredients, and social channels amplify both successes and missteps in communication. Retail dynamics are also shifting; omnichannel strategies blend subscription and direct-to-consumer fulfillment with traditional retail, prompting manufacturers to design packaging and formats optimized for each channel. Finally, regulatory scrutiny and evidence expectations are intensifying globally, prompting manufacturers to invest in clinical validation and to articulate benefit profiles with greater scientific precision. Together, these shifts are fostering a more sophisticated, evidence-driven, and consumer-responsive category.
Practical consequences of the 2025 United States tariff adjustments on sourcing, formulation strategies and supply chain resilience across digestive health product value chains
United States tariff adjustments announced in 2025 have produced ripple effects across procurement, supply chain architecture, and cost-to-market considerations for manufacturers and ingredient suppliers alike. Import-dependent companies are reevaluating supplier relationships and regional sourcing strategies to mitigate increased landed costs and to preserve margin structures without compromising product integrity. In response, firms are accelerating qualification of alternative suppliers, negotiating longer-term contracts, and exploring nearshoring where feasible to reduce exposure to tariff volatility.
Operationally, tariff pressures are incentivizing investment in formulation efficiency and ingredient substitution strategies that maintain functional performance while optimizing cost. Research and development teams are prioritizing multi-source ingredient compatibility and modular recipes that can accommodate regional supply differences without necessitating full-scale reformulation. Meanwhile, commercial teams are recalibrating pricing strategies and channel promotions to maintain competitive accessibility, with an emphasis on preserving perceived value through transparent communication about provenance and performance. Across the value chain, stakeholders are increasing scenario planning and stress-testing their supply networks to preserve continuity of supply and protect consumer trust amid a shifting trade environment.
Comprehensive segmentation insights that bridge product form, ingredient strategy, consumer age cohorts and channel dynamics to guide targeted development and commercialization
Segmentation analysis reveals distinct strategic imperatives across product, ingredient, form, age group, and distribution axes that inform development and commercialization choices. Based on product type, manufacturers must navigate a bifurcated landscape where Drinks - encompassing dairy-based formats such as kefir and yogurt drinks, and non-dairy options like kombucha and probiotic juices - emphasize beverage-specific texture, shelf stability, and on-the-go convenience, while Foods - spanning dairy items such as cheese and yogurt and non-dairy offerings like functional ingredients and snack bars - require softer claims architecture and in some cases higher-fiber or protein complements to deliver sustained digestive benefits. This duality necessitates cross-functional expertise in both beverage processing and solid-food formulation.
Based on ingredient type, the competitive frontier centers on prebiotics, probiotics, and synbiotics, with prebiotic categories leveraging fibers such as fructooligosaccharides, galactooligosaccharides, and inulin to support select microbial pathways; probiotic strategies prioritizing strains such as Bifidobacterium and Lactobacillus chosen for strain-specific outcomes; and synbiotic combinations designed to synergize substrate and microbe for targeted efficacy. Based on form, product developers must balance liquid formats like concentrates and ready-to-drink solutions against powders including drink mixes and ingredient powders, and solids such as bars, capsules, and tablets, each presenting distinct stability, shelf-life, and consumer usage considerations. Based on age group, formulations and claims must be calibrated for adults, children, and geriatric populations, accounting for differing physiological needs and regulatory boundaries. Based on distribution channel, brands must craft tailored value propositions for convenience stores, online retail platforms, pharmacy and drugstore environments, specialty stores, and supermarkets and hypermarkets, optimizing packaging, pricing, and promotional tactics to match channel-specific shopper behaviors.
Regional differentiation and strategic priorities across the Americas, Europe Middle East & Africa and Asia-Pacific that determine regulatory approach, product design and channel focus
Regional dynamics shape product priorities, regulatory pathways, and commercial models in meaningful ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions, each presenting distinctive opportunities and constraints. In the Americas, consumer demand favors convenient daily formats and a blend of evidence-backed functional claims with approachable branding; regulatory pathways emphasize substantiation and transparent labeling, while retailers prioritize shelf-ready innovations that drive repeat consumption. Cross-border supply and ingredient sourcing strategies often begin in the Americas and ripple outward, creating a hub for collaborations between ingredient science and consumer-facing brands.
In Europe, Middle East & Africa, product propositions must navigate a heterogenous regulatory landscape, varying cultural attitudes toward fermented and dairy-based products, and diverse retail architectures that range from traditional grocery to emerging digital platforms. Here, localized clinical data and careful claim wording are particularly important to establish trust. In the Asia-Pacific region, rapid urbanization and digital channel penetration are accelerating demand for novel convenient formats and traditional fermented products reinterpreted through modern ingredient science; manufacturers operating in this region often prioritize scalability, cost-efficiency, and rapid iteration to keep pace with fluid consumer trends. Across regions, supply chain design, ingredient validation, and market communication must be adapted to align with local taste preferences, regulatory frameworks, and distribution ecosystems.
Corporate strategies and partnership models among legacy manufacturers, ingredient specialists and startups that define competitive advantage and speed to market
Key company dynamics in the digestive health category are characterized by a mix of established consumer goods manufacturers, ingredient-specialist firms, and agile challengers focused on niche claims or novel delivery systems. Established manufacturers leverage scale, distribution relationships, and brand equity to introduce platform-level innovations and to invest in clinical programs that support premium positioning. Ingredient-specialist companies, in contrast, capitalize on scientific depth and supply expertise to create differentiated inputs that enable downstream manufacturers to claim targeted benefits. Startups and direct-to-consumer challengers often move fastest, experimenting with subscription models, personalized solutions, or hybrid formats that combine indulgence with function.
Partnerships between these archetypes are becoming more common, as legacy brands seek speed and technical novelty while smaller firms require distribution breadth and regulatory know-how. Collaboration models span co-development agreements, licensing of proprietary strains or prebiotic blends, and joint clinical studies that align evidence generation with commercialization plans. Across firm types, successful organizations are those that blend credible science with consumer-centric design, invest in robust supply chain governance, and maintain flexible commercialization strategies to respond to channel-specific demands and shifting regulatory expectations.
Actionable strategic imperatives for R&D, supply chain robustness and channel-tailored commercialization to secure long-term leadership in digestive health products
Industry leaders seeking to capture durable value in digestive health should adopt a coordinated strategy that spans R&D, supply chain, and commercial execution. Prioritize the development of evidence-backed product concepts by integrating translational science early in the innovation pipeline and by designing clinical programs that address both mechanism and consumer-relevant outcomes. Simultaneously, build formulation frameworks that allow modular substitution of ingredients to reduce dependence on single-source suppliers and to enable rapid adaptation to tariff or supply disruptions.
On the commercial front, tailor offerings to channel-specific expectations by aligning format, packaging, and pricing with shopper behaviors across convenience stores, e-commerce, pharmacies, specialty outlets, and large-format grocery. Invest in transparent storytelling that clearly communicates mechanism, ingredient provenance, and appropriate usage to build consumer trust. Lastly, pursue strategic collaborations-licensing, co-development, and targeted acquisitions-that accelerate access to novel strains, prebiotic technologies, and manufacturing capabilities. By coordinating scientific rigor, operational resilience, and channel-sensitive commercialization, leaders can sustain consumer trust while driving category relevance.
Methodology combining primary stakeholder interviews, systematic product audits and scientific literature triangulation to generate actionable insights for industry decision-makers
This research synthesizes primary stakeholder interviews, ingredient and category literature reviews, and systematic product audits to construct an evidence-informed perspective on digestive health products and commercial dynamics. Primary engagements included interviews with R&D and regulatory executives, ingredient developers, retail buyers, and clinicians to surface practical challenges and emerging priorities. Product audits encompassed a cross-section of beverages and foods across global retail channels to identify formulation patterns, claim language, and packaging innovations that indicate directional trends.
Secondary analyses drew on peer-reviewed nutrition and microbiome research to contextualize ingredient function and to evaluate claim substantiation frameworks. Supply chain and policy impacts were assessed through industry reports, customs data summaries, and trade policy announcements to understand practical implications for sourcing and cost structures. Throughout the methodology, triangulation was used to validate insights across data sources, and findings were reviewed by subject matter experts to ensure analytical rigor and practical relevance for commercial decision-makers.
Concluding perspective on how scientific credibility, consumer-centric design and operational resilience collectively determine success in the digestive health category
In conclusion, the digestive health drinks and functional foods category stands at an inflection point where scientific maturity, consumer sophistication, and commercial inventiveness converge to create new pathways for value creation. Product success will increasingly hinge on the intersection of credible evidence, sensory and convenience-led design, and resilient supply chain strategies that can withstand trade and sourcing fluctuations. Brands that invest in robust clinical validation, modular formulation workstreams, and channel-specific merchandising will be better positioned to convert consumer interest into sustained adoption.
Looking ahead, the most successful organizations will view regulatory engagement, cross-sector partnerships, and iterative consumer testing not as ancillary activities but as core components of product strategy. By aligning scientific rigor with pragmatic go-to-market execution, companies can accelerate the translation of microbiome science into accessible, delightful, and trusted products that meet a broad spectrum of digestive health needs.
Please Note: PDF & Excel + Online Access - 1 Year
A modern orientation to digestive health beverages and functional foods that explains evolving consumer motivations, clinical validation trends and cross-sector innovation dynamics
The digestive health drinks and functional foods category has matured from niche wellness fare into a mainstream platform for nutrition-led consumer engagement, supported by expanding scientific evidence and diversified ingredient technology. Consumers now approach digestive wellness through multiple avenues: daily preventative routines, condition-specific management, and integrative approaches that pair nutrition with lifestyle behaviors. These drivers have informed a broader ecosystem in which product developers, ingredient suppliers, clinicians, and retailers collaborate to translate biological mechanisms into credible consumer propositions. As a result, formulations emphasize tangible physiological benefits that are communicated with greater clarity and regulatory consciousness.
At the same time, commercial actors are balancing sensory experience, convenience, and efficacy to broaden appeal beyond motivated early adopters. Packaging innovations, portion formats, and hybrid product concepts aim to lower barriers to trial while preserving functional integrity. In parallel, industry stakeholders are investing in evidence generation-ranging from in vitro assays to real-world consumer studies-to underpin claims and differentiate offerings in a crowded shelf set. These intersecting trends are reshaping how digestive health products are developed, marketed, and distributed, creating a landscape where scientific legitimacy and consumer-centric design jointly determine competitive positioning.
How ingredient science, consumer expectations, omnichannel distribution and regulatory focus are jointly reshaping product development and commercial strategies in digestive health
Several transformative shifts are reconfiguring the digestive health category, driven by advances in ingredient science, shifts in consumer behavior, and new go-to-market models. Ingredient innovation is expanding beyond traditional probiotic strains to include targeted prebiotics, synbiotic combinations, and strain-specific applications that address distinct physiological pathways. These advances are enabling more precise product positioning-whether aimed at daily microbiome maintenance, post-antibiotic recovery, or symptom-focused relief-while increasing demands for transparent sourcing and traceability.
Consumer expectations are evolving as well: convenience and multisensory pleasure now coexist with a requirement for credible health outcomes and ethical practices. Digital-native shoppers are using online resources to validate claims and compare ingredients, and social channels amplify both successes and missteps in communication. Retail dynamics are also shifting; omnichannel strategies blend subscription and direct-to-consumer fulfillment with traditional retail, prompting manufacturers to design packaging and formats optimized for each channel. Finally, regulatory scrutiny and evidence expectations are intensifying globally, prompting manufacturers to invest in clinical validation and to articulate benefit profiles with greater scientific precision. Together, these shifts are fostering a more sophisticated, evidence-driven, and consumer-responsive category.
Practical consequences of the 2025 United States tariff adjustments on sourcing, formulation strategies and supply chain resilience across digestive health product value chains
United States tariff adjustments announced in 2025 have produced ripple effects across procurement, supply chain architecture, and cost-to-market considerations for manufacturers and ingredient suppliers alike. Import-dependent companies are reevaluating supplier relationships and regional sourcing strategies to mitigate increased landed costs and to preserve margin structures without compromising product integrity. In response, firms are accelerating qualification of alternative suppliers, negotiating longer-term contracts, and exploring nearshoring where feasible to reduce exposure to tariff volatility.
Operationally, tariff pressures are incentivizing investment in formulation efficiency and ingredient substitution strategies that maintain functional performance while optimizing cost. Research and development teams are prioritizing multi-source ingredient compatibility and modular recipes that can accommodate regional supply differences without necessitating full-scale reformulation. Meanwhile, commercial teams are recalibrating pricing strategies and channel promotions to maintain competitive accessibility, with an emphasis on preserving perceived value through transparent communication about provenance and performance. Across the value chain, stakeholders are increasing scenario planning and stress-testing their supply networks to preserve continuity of supply and protect consumer trust amid a shifting trade environment.
Comprehensive segmentation insights that bridge product form, ingredient strategy, consumer age cohorts and channel dynamics to guide targeted development and commercialization
Segmentation analysis reveals distinct strategic imperatives across product, ingredient, form, age group, and distribution axes that inform development and commercialization choices. Based on product type, manufacturers must navigate a bifurcated landscape where Drinks - encompassing dairy-based formats such as kefir and yogurt drinks, and non-dairy options like kombucha and probiotic juices - emphasize beverage-specific texture, shelf stability, and on-the-go convenience, while Foods - spanning dairy items such as cheese and yogurt and non-dairy offerings like functional ingredients and snack bars - require softer claims architecture and in some cases higher-fiber or protein complements to deliver sustained digestive benefits. This duality necessitates cross-functional expertise in both beverage processing and solid-food formulation.
Based on ingredient type, the competitive frontier centers on prebiotics, probiotics, and synbiotics, with prebiotic categories leveraging fibers such as fructooligosaccharides, galactooligosaccharides, and inulin to support select microbial pathways; probiotic strategies prioritizing strains such as Bifidobacterium and Lactobacillus chosen for strain-specific outcomes; and synbiotic combinations designed to synergize substrate and microbe for targeted efficacy. Based on form, product developers must balance liquid formats like concentrates and ready-to-drink solutions against powders including drink mixes and ingredient powders, and solids such as bars, capsules, and tablets, each presenting distinct stability, shelf-life, and consumer usage considerations. Based on age group, formulations and claims must be calibrated for adults, children, and geriatric populations, accounting for differing physiological needs and regulatory boundaries. Based on distribution channel, brands must craft tailored value propositions for convenience stores, online retail platforms, pharmacy and drugstore environments, specialty stores, and supermarkets and hypermarkets, optimizing packaging, pricing, and promotional tactics to match channel-specific shopper behaviors.
Regional differentiation and strategic priorities across the Americas, Europe Middle East & Africa and Asia-Pacific that determine regulatory approach, product design and channel focus
Regional dynamics shape product priorities, regulatory pathways, and commercial models in meaningful ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions, each presenting distinctive opportunities and constraints. In the Americas, consumer demand favors convenient daily formats and a blend of evidence-backed functional claims with approachable branding; regulatory pathways emphasize substantiation and transparent labeling, while retailers prioritize shelf-ready innovations that drive repeat consumption. Cross-border supply and ingredient sourcing strategies often begin in the Americas and ripple outward, creating a hub for collaborations between ingredient science and consumer-facing brands.
In Europe, Middle East & Africa, product propositions must navigate a heterogenous regulatory landscape, varying cultural attitudes toward fermented and dairy-based products, and diverse retail architectures that range from traditional grocery to emerging digital platforms. Here, localized clinical data and careful claim wording are particularly important to establish trust. In the Asia-Pacific region, rapid urbanization and digital channel penetration are accelerating demand for novel convenient formats and traditional fermented products reinterpreted through modern ingredient science; manufacturers operating in this region often prioritize scalability, cost-efficiency, and rapid iteration to keep pace with fluid consumer trends. Across regions, supply chain design, ingredient validation, and market communication must be adapted to align with local taste preferences, regulatory frameworks, and distribution ecosystems.
Corporate strategies and partnership models among legacy manufacturers, ingredient specialists and startups that define competitive advantage and speed to market
Key company dynamics in the digestive health category are characterized by a mix of established consumer goods manufacturers, ingredient-specialist firms, and agile challengers focused on niche claims or novel delivery systems. Established manufacturers leverage scale, distribution relationships, and brand equity to introduce platform-level innovations and to invest in clinical programs that support premium positioning. Ingredient-specialist companies, in contrast, capitalize on scientific depth and supply expertise to create differentiated inputs that enable downstream manufacturers to claim targeted benefits. Startups and direct-to-consumer challengers often move fastest, experimenting with subscription models, personalized solutions, or hybrid formats that combine indulgence with function.
Partnerships between these archetypes are becoming more common, as legacy brands seek speed and technical novelty while smaller firms require distribution breadth and regulatory know-how. Collaboration models span co-development agreements, licensing of proprietary strains or prebiotic blends, and joint clinical studies that align evidence generation with commercialization plans. Across firm types, successful organizations are those that blend credible science with consumer-centric design, invest in robust supply chain governance, and maintain flexible commercialization strategies to respond to channel-specific demands and shifting regulatory expectations.
Actionable strategic imperatives for R&D, supply chain robustness and channel-tailored commercialization to secure long-term leadership in digestive health products
Industry leaders seeking to capture durable value in digestive health should adopt a coordinated strategy that spans R&D, supply chain, and commercial execution. Prioritize the development of evidence-backed product concepts by integrating translational science early in the innovation pipeline and by designing clinical programs that address both mechanism and consumer-relevant outcomes. Simultaneously, build formulation frameworks that allow modular substitution of ingredients to reduce dependence on single-source suppliers and to enable rapid adaptation to tariff or supply disruptions.
On the commercial front, tailor offerings to channel-specific expectations by aligning format, packaging, and pricing with shopper behaviors across convenience stores, e-commerce, pharmacies, specialty outlets, and large-format grocery. Invest in transparent storytelling that clearly communicates mechanism, ingredient provenance, and appropriate usage to build consumer trust. Lastly, pursue strategic collaborations-licensing, co-development, and targeted acquisitions-that accelerate access to novel strains, prebiotic technologies, and manufacturing capabilities. By coordinating scientific rigor, operational resilience, and channel-sensitive commercialization, leaders can sustain consumer trust while driving category relevance.
Methodology combining primary stakeholder interviews, systematic product audits and scientific literature triangulation to generate actionable insights for industry decision-makers
This research synthesizes primary stakeholder interviews, ingredient and category literature reviews, and systematic product audits to construct an evidence-informed perspective on digestive health products and commercial dynamics. Primary engagements included interviews with R&D and regulatory executives, ingredient developers, retail buyers, and clinicians to surface practical challenges and emerging priorities. Product audits encompassed a cross-section of beverages and foods across global retail channels to identify formulation patterns, claim language, and packaging innovations that indicate directional trends.
Secondary analyses drew on peer-reviewed nutrition and microbiome research to contextualize ingredient function and to evaluate claim substantiation frameworks. Supply chain and policy impacts were assessed through industry reports, customs data summaries, and trade policy announcements to understand practical implications for sourcing and cost structures. Throughout the methodology, triangulation was used to validate insights across data sources, and findings were reviewed by subject matter experts to ensure analytical rigor and practical relevance for commercial decision-makers.
Concluding perspective on how scientific credibility, consumer-centric design and operational resilience collectively determine success in the digestive health category
In conclusion, the digestive health drinks and functional foods category stands at an inflection point where scientific maturity, consumer sophistication, and commercial inventiveness converge to create new pathways for value creation. Product success will increasingly hinge on the intersection of credible evidence, sensory and convenience-led design, and resilient supply chain strategies that can withstand trade and sourcing fluctuations. Brands that invest in robust clinical validation, modular formulation workstreams, and channel-specific merchandising will be better positioned to convert consumer interest into sustained adoption.
Looking ahead, the most successful organizations will view regulatory engagement, cross-sector partnerships, and iterative consumer testing not as ancillary activities but as core components of product strategy. By aligning scientific rigor with pragmatic go-to-market execution, companies can accelerate the translation of microbiome science into accessible, delightful, and trusted products that meet a broad spectrum of digestive health needs.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
199 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Rising demand for synbiotic snacks combining probiotics and prebiotic fibers to enhance digestive balance
- 5.2. Innovation in personalized gut microbiome testing driving custom digestive health food formulations
- 5.3. Growing popularity of fermented plant-based dairy alternatives targeting gut microbiota diversity
- 5.4. Inclusion of digestive enzymes in functional beverages for accelerated nutrient breakdown and absorption
- 5.5. Adoption of low FODMAP labeling in snacks and drinks to cater to consumers with IBS sensitivities
- 5.6. Emergence of mushroom-based functional drinks containing chaga and reishi to support stomach health
- 5.7. Use of resistant starch from green banana flour in bakery items to feed beneficial gut bacteria
- 5.8. Cross category collaborations between beverage companies and microbiome startups for targeted gut therapies
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Digestive Health Drinks & Food Market, by Product Type
- 8.1. Drinks
- 8.1.1. Dairy Drinks
- 8.1.1.1. Kefir
- 8.1.1.2. Yogurt Drinks
- 8.1.2. Non-Dairy Drinks
- 8.1.2.1. Kombucha
- 8.1.2.2. Probiotic Juices
- 8.2. Foods
- 8.2.1. Dairy Foods
- 8.2.1.1. Cheese
- 8.2.1.2. Yogurt
- 8.2.2. Non-Dairy Foods
- 8.2.2.1. Functional Ingredients
- 8.2.2.2. Snack Bars
- 9. Digestive Health Drinks & Food Market, by Ingredient Type
- 9.1. Prebiotics
- 9.1.1. Fructooligosaccharides
- 9.1.2. Galactooligosaccharides
- 9.1.3. Inulin
- 9.2. Probiotics
- 9.2.1. Bifidobacterium
- 9.2.2. Lactobacillus
- 9.3. Synbiotics
- 9.3.1. Combination Probiotic Prebiotic
- 10. Digestive Health Drinks & Food Market, by Form
- 10.1. Liquid
- 10.1.1. Concentrate
- 10.1.2. Ready To Drink
- 10.2. Powder
- 10.2.1. Drink Mix
- 10.2.2. Ingredient Powder
- 10.3. Solid
- 10.3.1. Bars
- 10.3.2. Capsules
- 10.3.3. Tablets
- 11. Digestive Health Drinks & Food Market, by Age Group
- 11.1. Adults
- 11.2. Children
- 11.3. Geriatric
- 12. Digestive Health Drinks & Food Market, by Distribution Channel
- 12.1. Convenience Stores
- 12.2. Online Retail
- 12.3. Pharmacy & Drugstores
- 12.4. Specialty Stores
- 12.5. Supermarkets & Hypermarkets
- 13. Digestive Health Drinks & Food Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Digestive Health Drinks & Food Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Digestive Health Drinks & Food Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. Arla Foods Ingredients Group P/S
- 16.3.2. Bayer AG
- 16.3.3. BioGaia AB
- 16.3.4. Chr. Hansen Holding A/S
- 16.3.5. Danone S.A.
- 16.3.6. DuPont de Nemours, Inc.
- 16.3.7. Fonterra Co-operative Group Limited
- 16.3.8. FrieslandCampina N.V.
- 16.3.9. General Mills, Inc.
- 16.3.10. Herbalife Nutrition Ltd.
- 16.3.11. International Flavors & Fragrances Inc.
- 16.3.12. Kerry Group plc
- 16.3.13. Lactalis S.A.
- 16.3.14. Lallemand Inc.
- 16.3.15. Meiji Holdings Co., Ltd.
- 16.3.16. Mondelez International, Inc.
- 16.3.17. Nestlé S.A.
- 16.3.18. PepsiCo, Inc.
- 16.3.19. Probi AB
- 16.3.20. The Coca-Cola Company
- 16.3.21. The Kraft Heinz Company
- 16.3.22. Yakult Honsha Co., Ltd.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
